Anna Ozaki

637 total citations
16 papers, 306 citations indexed

About

Anna Ozaki is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Anna Ozaki has authored 16 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Anna Ozaki's work include Liver Disease Diagnosis and Treatment (11 papers), Diet, Metabolism, and Disease (5 papers) and Liver Disease and Transplantation (3 papers). Anna Ozaki is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Diet, Metabolism, and Disease (5 papers) and Liver Disease and Transplantation (3 papers). Anna Ozaki collaborates with scholars based in Japan and Singapore. Anna Ozaki's co-authors include Masato Yoneda, Takaomi Kessoku, Yasushi Honda, Takashi Kobayashi, Atsushi Nakajima, Kento Imajo, Yuji Ogawa, Satoru Saito, Michihiro Iwaki and Hiroyuki Kirikoshi and has published in prestigious journals such as International Journal of Molecular Sciences, Clinical Gastroenterology and Hepatology and The Oncologist.

In The Last Decade

Anna Ozaki

16 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Ozaki Japan 7 251 116 104 54 50 16 306
Abbey Barnard United States 6 274 1.1× 89 0.8× 173 1.7× 44 0.8× 47 0.9× 8 326
Claudia La Mantia Italy 8 240 1.0× 92 0.8× 119 1.1× 31 0.6× 50 1.0× 17 298
M.-C. Brindisi France 6 261 1.0× 173 1.5× 105 1.0× 43 0.8× 42 0.8× 13 357
Shui-Xian Du China 8 301 1.2× 106 0.9× 142 1.4× 40 0.7× 32 0.6× 12 328
Cristina Muzîca Romania 9 263 1.0× 78 0.7× 174 1.7× 40 0.7× 58 1.2× 48 364
Cameron Gofton Australia 5 238 0.9× 122 1.1× 77 0.7× 26 0.5× 51 1.0× 9 303
Efthimia Zafeiriadou Greece 8 251 1.0× 161 1.4× 74 0.7× 124 2.3× 34 0.7× 9 348
Hilde Løland von Volkmann Norway 7 267 1.1× 190 1.6× 76 0.7× 68 1.3× 88 1.8× 13 366
Elmer Schabel Germany 6 236 0.9× 103 0.9× 120 1.2× 43 0.8× 22 0.4× 8 266
Sebastian Zenovia Romania 9 216 0.9× 75 0.6× 131 1.3× 30 0.6× 41 0.8× 31 284

Countries citing papers authored by Anna Ozaki

Since Specialization
Citations

This map shows the geographic impact of Anna Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ozaki more than expected).

Fields of papers citing papers by Anna Ozaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ozaki. The network helps show where Anna Ozaki may publish in the future.

Co-authorship network of co-authors of Anna Ozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Ozaki. A scholar is included among the top collaborators of Anna Ozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Ozaki. Anna Ozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tanaka, Kosuke, Hidenori Ohkubo, Atsushi Yamamoto, et al.. (2023). Natural History of Chronic Intestinal Pseudo-obstruction and Need for Palliative Care. Journal of Neurogastroenterology and Motility. 29(3). 378–387. 4 indexed citations
2.
Iwaki, Michihiro, Takaomi Kessoku, Kosuke Tanaka, et al.. (2023). Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease. Hepatology Communications. 7(11). 3 indexed citations
3.
Iwaki, Michihiro, Takaomi Kessoku, Kosuke Tanaka, et al.. (2022). Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease. JGH Open. 6(10). 696–703. 5 indexed citations
4.
Iwaki, Michihiro, Takaomi Kessoku, Kosuke Tanaka, et al.. (2022). Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study. BMJ Open. 12(7). e060335–e060335. 2 indexed citations
5.
Yoneda, Masato, Yasushi Honda, Yuji Ogawa, et al.. (2021). Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial. BMJ Open Diabetes Research & Care. 9(1). e001990–e001990. 78 indexed citations
6.
Honda, Yasushi, Anna Ozaki, Michihiro Iwaki, et al.. (2021). Protective effect of SGL5213, a potent intestinal sodium–glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice. Journal of Pharmacological Sciences. 147(2). 176–183. 6 indexed citations
7.
Ozaki, Anna, Takaomi Kessoku, Yuki Kasai, et al.. (2021). Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake. The Oncologist. 26(10). e1862–e1869. 4 indexed citations
8.
Kessoku, Takaomi, Takashi Kobayashi, Kosuke Tanaka, et al.. (2021). The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. International Journal of Molecular Sciences. 22(15). 8161–8161. 49 indexed citations
9.
Kobayashi, Takashi, Takaomi Kessoku, Anna Ozaki, et al.. (2021). Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial. Journal of Clinical Biochemistry and Nutrition. 68(2). 181–186. 18 indexed citations
10.
11.
Imajo, Kento, Yasushi Honda, Takashi Kobayashi, et al.. (2020). Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 20(4). 908–917.e11. 85 indexed citations
12.
Kessoku, Takaomi, Noritoshi Kobayashi, Masato Yoneda, et al.. (2020). Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype. Frontiers in Oncology. 10. 555963–555963. 3 indexed citations
13.
14.
Imajo, Kento, Anna Ozaki, Takashi Kobayashi, et al.. (2020). Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver. Diagnostics. 10(3). 129–129. 24 indexed citations
15.
Ozaki, Anna, Masato Yoneda, Takaomi Kessoku, et al.. (2019). Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study). Contemporary Clinical Trials Communications. 17. 100516–100516. 11 indexed citations
16.
Adachi, Seiji, et al.. (1993). [A case report of sarcoid reactions with hepatocellular carcinoma and two early gastric carcinomas].. PubMed. 94(5). 534–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abbey Barnard Breakdown of academic impact, for papers by Claudia La Mantia Breakdown of academic impact, for papers by M.-C. Brindisi Breakdown of academic impact, for papers by Shui-Xian Du Breakdown of academic impact, for papers by Cristina Muzîca Breakdown of academic impact, for papers by Cameron Gofton Breakdown of academic impact, for papers by Efthimia Zafeiriadou Breakdown of academic impact, for papers by Hilde Løland von Volkmann Breakdown of academic impact, for papers by Elmer Schabel Breakdown of academic impact, for papers by Sebastian Zenovia
Rankless by CCL
2026